After propensity score matching against multiple antidiabetic drug classes (insulin, metformin, SGLT-2 inhibitors, DPP-4 inhibitors, sulfonylureas), results showed: No significant increase in thyroid cancer incidence Median follow-up of ~4.5 years Risk estimates comparable or lower than other glucose-lowering therapies Overall, current epidemiological evidence does not support a clinically meaningful increase in thyroid cancer risk in humans
The prevalence of AMS generally depends on the altitude attained and speed of ascent
By mimicking native fullness hormones at an advanced clinical volume, it slows down the rate at which food leaves your stomach
Ferraro, B
2 Nitric oxide is synthesized in the body primarily from the amino acid L-arginine
Diabetes, Obesity & Metabolism, 25(1), 317